AI Article Synopsis
Article Abstract
Although children and adolescents with cancer often experience symptoms of anxiety and depression, there are no published data regarding the use of selective serotonin reuptake inhibitors (SSRIs) for treating depression in the pediatric oncology population. The goal of this study was to characterize SSRI prescribing practices among pediatric oncologists. A brief (14 item) written survey was distributed to all attending and fellow physicians at a large center with an 85% response rate (N = 40). Half of the respondents prescribed SSRIs for patients, and the most common triggers for prescription include oncologist perceptions of the patient's general sadness, major depressive disorder, and anxiety. The majority of oncologists in the sample (70%) used more than one SSRI. Most physicians prescribe during the first year of therapy and 50% feel that their practice will be influenced by the Federal Drug Administration (FDA) warnings governing the use of SSRIs in the pediatric population. Some physicians consult hospital psychologists, while fewer consult psychiatrists prior to prescribing for these patients. The information gathered from this survey demonstrates that pediatric oncologists are prescribing SSRIs for their patients for a variety of indications. Prospective clinical trials that involve screening patients for depression and anxiety prior to and following SSRI therapy may be helpful in determining whether they result in amelioration of symptoms. It would also be important to evaluate the benefits of a concurrent psychological intervention with medication.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pbc.20484 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical utility of receptor status prediction in breast cancer and misdiagnosis identification using deep learning on hematoxylin and eosin-stained slides.
Commun Med (Lond)
December 2024
Department of Computer Science, Technion-Israel Institue of Technology, Haifa, Israel.
Background: Molecular profiling of estrogen receptor (ER), progesterone receptor (PR), and ERBB2 (also known as Her2) is essential for breast cancer diagnosis and treatment planning. Nevertheless, current methods rely on the qualitative interpretation of immunohistochemistry and fluorescence in situ hybridization (FISH), which can be costly, time-consuming, and inconsistent. Here we explore the clinical utility of predicting receptor status from digitized hematoxylin and eosin-stained (H&E) slides using machine learning trained and evaluated on a multi-institutional dataset.
View Article and Find Full Text PDF[Patients' perceptions of teleconsultation in long-term follow-up after pediatric cancer].
Bull Cancer
December 2024
INSERM, Aix Marseille université, IRD, ISSPAM, SESSTIM, sciences économiques et sociales de la santé et traitement de l'information médicale, équipe CALIPSO, 27, boulevard Jean-Moulin, 13385 Marseille cedex, France.
For the past decade, "long-term follow-up consultations" have been established for adults cured of pediatric cancer to ensure the prevention, early detection, and treatment of long-term effects. These consultations are now sometimes conducted in the form of teleconsultations, a practice that has seen significant growth following the COVID-19 crisis. The objective of this study was to evaluate the satisfaction, usefulness, and patient experience of teleconsultations conducted by an oncologist or hematologist as part of the long-term follow-up of adults cured of pediatric cancer.
View Article and Find Full Text PDF[Vaccination of children and adolescents treated for acute leukemia, excluding HSCT recipients: Recommendations of the French Society for Childhood and Adolescent Cancer and Leukemia (SFCE)].
Bull Cancer
December 2024
Service d'oncologie hématologie pédiatrique, hôpital universitaire Armand-Trousseau (AP-HP), Paris, France; Centre d'investigations cliniques, hôpital Cochin, Paris, France. Electronic address:
Children and adolescents who are being treated or have been treated for acute leukemia have a secondary immunodeficiency linked to chemotherapy, resulting in an increased risk of infections. Some of which can be prevented by vaccination but its effectiveness is not optimal during chemotherapy. Upon cessation of chemotherapy, the time required for immune reconstitution varies from three months to more than a year, depending on lymphocyte subpopulations, the patient's age, and the intensity of the treatment received.
View Article and Find Full Text PDFNational virtual tumor boards to inform the management of children with rare cancers.
Curr Opin Pediatr
February 2025
Baylor College of Medicine, Department of Pediatrics, Division of Hematology Oncology, Houston, Texas.
Purpose Of Review: Due to the infrequent nature of rare pediatric cancers, rigorously studied treatment algorithms are usually nonexistent, and experience with a given tumor may be limited at a single institution. Development of treatment plans for these populations often requires extensive literature review and outreach to experts at other institutions. National or international virtual tumor boards provide a streamlined, collaborative approach to discussing diagnosis and management of these patients through dissemination of collective experience and knowledge.
View Article and Find Full Text PDFPurpose: Wiskott-Aldrich syndrome (WAS) is an X-linked genetic disorder characterized by distinctive features including microthrombocytopenia, eczema and recurrent infections. In the present study we report clinical, immunological and molecular spectrum of 41 WAS patients diagnosed over last five years.
Methods: Clinical and family history was collected from case records.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!